← All organizations

RayzeBio, Inc.

For profitWebsite ↗

Also known as: RayzeBio, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Nov 13, 2025

Acquired by Bristol-Myers Squibb on Dec 6, 2023

Timeline

2010s

Jan 1, 2018
RayzeBio, Inc.— Founded

2020s

Dec 6, 2023
Bristol-Myers Squibb— Acquired By

Drugs by trial phase (11 distinct, 7 trials)

Phase 2 (6 own, 0 via acquisition)

Phase 1 (5 own, 0 via acquisition)

Recent trials (11)

NCT07150806CollaboratorPhase 1/Phase 2Nov 13, 2025
NCT07165132OfficialPhase 1Oct 31, 2025
NCT07165132Lead sponsorPhase 1Oct 31, 2025
NCT06726161Lead sponsorPhase 1Dec 31, 2024
NCT06726161OfficialPhase 1Dec 31, 2024
NCT06411301CollaboratorPhase 1Oct 31, 2024
NCT06590857Lead sponsorPhase 1/Phase 2Jul 19, 2024
NCT06590857OfficialPhase 1/Phase 2Jul 19, 2024
NCT05595460Lead sponsorPhase 1Oct 10, 2022
NCT05595460Study directorPhase 1Oct 10, 2022
NCT05477576Lead sponsorPhase 1/Phase 2Mar 24, 2022

Details

Founded: San Diego, CA, US Jan 1, 2018
Last known activity: Nov 13, 2025